,,ii  #aaf? ,,congress  #b;d ,session   
,s4 #cech  ,,9 ,,! ,,s5ate ,,( ,,!      
,,unit$ ,,/ates  ,m>* #ai1 #bjbj,mr4    
,rubio 7= himself1 ,ms4 ,w>r51 ,mr4     
,cram]1 ,mr4 ,murphy1 & ,mr4 ,ka9e7     
introduc$ ! foll[+ bill2 :i* 0 read     
twice & ref]r$ to ! ,committee on       
,f9ance  ,a ,,bill  ,to require !       
,secret>y ( ,def5se to submit to        
,congress a report on ! reliance by !   
,dep>tm5t ( ,def5se on imports ( c]ta9  
ph>maceutical products made 9 "p or 9   
:ole 9 c]ta9 c\ntries1 to e/abli%       
po/m>ket report+ requirem5ts =          
ph>maceuticals1 & = o!r purposes4  #a4  
,%ort title ,?is ,act may be cit$ z !   
,/r5g!n+ ,am]ica's ,supply ,*a9 &       
,national ,security ,act4  #b4 ,report  
on reliance by ,dep>tm5t ( ,def5se on   
ph>maceutical products f c]ta9 c\ntries 
7a7 ,9 g5]al ,n lat] ?an "o ye> aft] !  
date ( ! enactm5t ( ?is ,act1 !         
,secret>y ( ,def5se1 9 coord9ation ) !  
,secret>y ( ,heal? & ,human ,s]vices1   
%all submit to ! appropriate            

congressional committees a classifi$    
report on ! reliance by ! ,dep>tm5t (   
,def5se on imports ( c]ta9 ph>maceutical
 products made 9 "p or 9 :ole 9 a cov]$ 
c\ntry4  7b7 ,elem5ts ,! report requir$ 
by subsection 7a7 %all-- 7#a7 analyze ! 
p]c5t ( ph>maceutical products us$ by ! 
,dep>tm5t ( ,def5se t are made 9 "p or 9
 :ole 9 a cov]$ c\ntry1 includ+-- 7,a7  
drugs2  7,b7 active +r$i5ts2  7,c7 raw  
ph>maceutical compon5ts2  7,d7          
nonprescription drugs int5d$ = human    
use2 &  7,e7 any o!r ph>maceutical      
product1 or its compon5ts1 z ! ,secret>y
 consid]s appropriate2  7#b7 assess !   
products id5tifi$ "u p>agraph 7#a7 to   
det]m9e-- 7,a7 :e!r ! ,dep>tm5t (       
,def5se c procure ! product f o!r       
s\rces2  7,b7 :e!r reliance by !        
,dep>tm5t ( ,def5se on ! product is     
likely1 or has significant pot5tial1 to 
be us$ = a milit>y1 geopolitical1 or    
economic advantage aga9/ ! ,unit$       
,/ates2  7,c7 :e!r reliance on ! product
 creates a risk = ! ,unit$ ,/ates2 &    

7,d7 :at impact !re w\ld be if access to
 ! product 0 t]m9at$2  7#c7 set =?      
recomm5dations to ensure t by #bjbe no  
ph>maceutical products pur*as$ =        
b5efici>ies ( heal? c>e f ! ,dep>tm5t ( 
,def5se or any associat$ program are    
made 9 "p or 9 :ole 9 a cov]$ c\ntry2   
7#d7 assess ! resili5ce & capacity ( !  
curr5t supply *a9 & indu/rial base to   
support national def5se if no           
ph>maceutical products pur*as$ =        
b5efici>ies ( heal? c>e f ! ,dep>tm5t ( 
,def5se or any associat$ program are    
made 9 "p or 9 :ole 9 a cov]$ c\ntry1   
includ+ ) respect to-- 7,a7 !           
manufactur+ capacity ( ! ,unit$ ,/ates2 
7,b7 gaps 9 dome/ic manufactur+         
capabilities1 includ+ non-exi/5t1       
ext9ct1 ?reat5$1 & s+le-po9t-(-failure  
capabilities2 &  7,c7 supply *a9s ) s+le
 po9ts ( failure & limit$ resili5cy2    
7#e7 set =? recomm5dations-- 7,a7 to    
div]sify supply ( ph>maceutical products
 away f complete dep5d5cy on s\rces (   
supply 9 c\ntries t are competitors ( ! 

,unit$ ,/ates or politically un/able t  
may cut (f supply 9 ! ,unit$ ,/ates2    
7,b7 to address critical bottl5ecks 9 ! 
supply ( ph>maceutical products 9 !     
,unit$ ,/ates2 &  7,c7 to mitigate s+le 
po9ts ( failure & limit$ resili5ce (    
supply *a9s = ph>maceutical products 9 !
 ,unit$ ,/ates2 &  7#f7 set =?          
recomm5dations = legislative &          
adm9i/rative action necess>y to avoid1  
or prep>e =1 cont+5cies id5tifi$ 9 !    
report4  7c7 ,publication ( unclassifi$ 
summ>y ,concurr5t ) ! submittal ( !     
report requir$ by subsection 7a71 !     
,secret>y ( ,def5se %all publi% on a    
publicly available int]net website ( !  
,dep>tm5t ( ,def5se an unclassifi$      
summ>y ( ! report4  7d7 ,def9itions ,9  
?is section3 7#a7 ,appropriate          
congressional committees ,! t]m         
appropriate congressional committees    
means-- 7,a7 ! ,committee on ,arm$      
,s]vices1 ! ,select ,committee on       
,intellig5ce1 ! ,committee on ,f9ance1 !
 ,committee on ,bank+1 ,h\s+1 & ,urban  

,affairs1 & ! ,committee on ,heal?1     
,education1 ,labor1 & ,p5sions ( !      
,s5ate2 &  7,b7 ! ,committee on ,arm$   
,s]vices1 ! ,p]man5t ,select ,committee 
on ,intellig5ce1 ! ,committee on ,ways &
 ,means1 ! ,committee on ,f9ancial      
,s]vices1 & ! ,committee on ,en]gy &    
,comm]ce ( ! ,h\se ( ,repres5tatives4   
7#b7 ,cov]$ c\ntry ,! t]m cov]$ c\ntry  
means-- 7,a7 ,*9a2 &  7,b7 any o!r      
c\ntry z det]m9$ by ! ,secret>y (       
,def5se = national security purposes4   
7#c7 ,drug ,! t]m drug means a product  
subject to regulation "u section #eje or
 section #hjb ( ! ,f$]al ,food1 ,drug1 &
 ,cosmetic ,act 7#ba ,u4,s4,c4 #cee or  
#chb7 or "u section #cea ( ! ,public    
,heal? ,s]vice ,act 7#db ,u4,s4,c4      
#bfb74  7#d7 ,nonprescription drug ,!   
t]m nonprescription drug has ! mean+    
giv5 t t]m 9 section #gfj7;a77#b7 ( !   
,f$]al ,food1 ,drug1 & ,cosmetic ,act   
7#ba ,u4,s4,c4 #cgi;aa7a77#b774  #c4    
,modification ( rules ( orig9 =         
ph>maceutical products  7a7 ,trade      

agreem5ts ,section #cjh7d77;,b7 ( !     
,trade ,agreem5ts ,act ( #aigi 7#ai     
,u4,s4,c4 #beah7d77;,b77 is am5d$-- 7#a7
 9 clause 7i71 by /rik+ in/rum5tality1  
or & ins]t+ in/rum5tality12  7#b7 9     
clause 7ii7-- 7,a7 by ins]t+ 1 o!r ?an  
an active ph>maceutical +r$i5t1 aft] "p 
( mat]ials2 &  7,b7 by /rik+ ! p]iod at 
! end & ins]t+ 1 or2 &  7#c7 by ins]t+  
be=e ! p]iod at ! end ! foll[+3 7iii7 9 
! case ( an article :i* consi/s ( an    
active ph>maceutical +r$i5t1 !          
ph>maceutical +r$i5t is :olly ! gr[?1   
product1 or manufacture ( t c\ntry or   
in/rum5tality4  7b7 ,f$]al ,acquisition 
,regulation ,n lat] ?an #ahj days aft] !
 date ( ! enactm5t ( ?is ,act1 !        
,presid5t %all prescribe regulations to 
update sections #eb4bbe-e & #be4jjc (   
title #dh1 ,code ( ,f$]al ,regulations  
7or successor regulations7 to be        
consi/5t ) rules ( orig9 det]m9ations = 
active ph>maceutical +r$i5ts made "u    
section #cjh7d77;,b7 ( ! ,trade         
,agreem5ts ,act ( #aigi 7#ai ,u4,s4,c4  

#beah7d77;,b771 z am5d$ by subsection   
7a74  #d4 ,po/m>ket report+ requirem5ts 
= ph>maceuticals  7a7 ,9 g5]al ,!       
,secret>y ( ,heal? & ,human ,s]vices1   
act+ ?r\gh ! ,commission] ( ,food &     
,drugs1 %all ensure t ea* hold] ( an    
approv$ application "u section #eje ( ! 
,f$]al ,food1 ,drug1 & ,cosmetic ,act   
7#ba ,u4,s4,c4 #cee7 or "u section #cea 
( ! ,public ,heal? ,s]vice ,act 7#db    
,u4,s4,c4 #bfb7 annually submit1 z "p ( 
! po/m>ket annual report requir$ by !   
,secret>y "u section #cad4ha7;b77#b7 (  
title #ba1 ,code ( ,f$]al ,regulations  
7or any successor regulation71 ! foll[+ 
in=mation3 7#a7 ,! names & addresses ( !
 s\rces ( active & inactive +r$i5ts ( ! 
drug4  7#b7 ,= ea* active & inactive    
+r$i5t ( ! drug1 ! p]c5tage ( !         
aggregate am\nt ( su* +r$i5t us$ 9 !    
manufacture ( ! drug dur+ ! report+     
p]iod t is f ea* ( ! s\rces id5tifi$ "u 
p>agraph 7#a74  7b7 ,disclosure (       
,in=mation ,! ,secret>y ( ,heal? &      
,human ,s]vices %all-- 7#a7 annually    

provide ! in=mation report$ 9 p>agraphs 
7#a7 & 7#b7 ( subsection 7a7 to !       
,secret>y ( ,def5se = purposes ( und]/&+
 ! dep5d5cy on =eign manufactur]s (     
drugs us$ by memb]s ( ! ,arm$ ,=ces2 &  
7#b7 publi% ! in=mation report$ "u su*  
p>agraphs on a publicly available       
int]net website ( ! ,f$]al ,gov]nm5t 9 a
 s+le1 aggregate =m1 )\t disclos+       
propriet>y in=mation4